Blum KA. B-cell receptor pathway modulators in NHL. Hematology Am Soc Hematol Educ Program. 2015 ; 2015 : 82-91.
Vanhaesebroeck B, Perry MWD, Brown JR, et al. PI3K inhibitors are finally coming of age. Nat Rev Drug Discov. 2021 ; 20 : 741-69.
Bi L, Okabe I, Bernard DJ, et al. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem. 1999 ; 274: 10963-8.
Bi L, Okabe I, Bernard DJ, et al. Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm Genome. 2002 ; 13 : 169-72.
Paul J, Soujon M, Wengner AM, et al. Simultaneous Inhibition of PI3Kδand PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and-Independent Activation of NF-κB and AKT. Cancer Cell. 2017 ; 31 : 64-78.